| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4fa0842bb42edb2efbc5761561ce6e8b |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2059
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2013 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-22 |
| filingDate |
2004-09-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1a864543ae5d0b84252ce20aae94b2f6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_430624afc0e9e090bc9237c66e41d535
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8e76e2bf873c665247c11aaf86a583e0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_898e6e460cb811a40aa694b5b5930f0c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4758f163ea9087d586aa913205b7923a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_58886a6a104ad69c39ed1f1f7cc35ba1 |
| publicationDate |
2007-06-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20070061833-A |
| titleOfInvention |
Pharmaceutical composition for sustained release of hydralazine and its use as a support for cancer treatment |
| abstract |
The present invention relates to sustained release of hydralazine for use in the treatment of cancer. The sustained release form of hydralazine is used to obtain a constant concentration of the active ingredient in the blood, thereby enabling the demethylation effect of hydralazine without producing the hypotensive action of hydralazine, so that the composition of the present invention can be used to treat cancer. do. |
| priorityDate |
2007-03-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |